Stanford genomics professor: AI diagnosis isn't the real bottleneck for rare diseases
anshulkundaje · x · 2026-11-07
Genomics researcher Anshul Kundaje argues that while AI can speed up diagnosis interpretation for a relatively small share of rare disease cases, it's not the biggest bottleneck. Even if diagnosis is fully solved, therapeutic development remains non-trivial — delivering AAV, CRISPR, or small molecules to most causal cell types is still an unsolved problem.
Related event: Stanford professor argues rare disease bottleneck is biology, not AI(10 posts)→
More from AGI Musings
- Defenders Can Match 1,000 Attacking AI Agents—and Hold an Information Edge — marktenenholtz · 2026-11-08
- 'Old Man Yells at Moon' meme captures the coming AGI productivity paradox — yunta_tsai · 2026-11-08
- Agents Will Toxicify the Open Internet; Private High-Trust Networks Win — sull · 2026-11-08
- LLMs Are Now Both Authors and Reviewers, Quip Highlights Peer Review Loop — miniapeur · 2026-11-08
- 3,000 years of frozen family careers: why abundance, not money, expands life choices — yunta_tsai · 2026-11-08
- Box CEO Aaron Levie: AI Has Widened the Engineer Gap to at Least 100x — 2C_ornot2C · 2026-11-08